France Antimicrobial Susceptibility Testing Market Market Report 2023 to 2030

France Antimicrobial Susceptibility Testing Market Analysis

$ 3999

France Antimicrobial Susceptibility Testing Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Antimicrobial Susceptibility Testing is expanding as a result of increasing infectious diseases and rising research and development funding globally. This demand is fueling the development of better tools and methods for antimicrobial susceptibility testing market. Some of the key players in the global Antimicrobial Susceptibility Testing Market include Bio-Rad Laboratories Inc.; Merck & Co., Inc.; Thermo Fisher Scientific Inc.; Danaher Corporation; BD; bioM?rieux SA; Creative Diagnostics; Hi-Media Laboratories Pvt. Ltd.; ELITechGroup; and F. Hoffmann-La Roche Ltd.

ID: IN10FRHS021 CATEGORY: Healthcare Services GEOGRAPHY: France AUTHOR: Dr. Nensi Savani

Buy Now

France Antimicrobial Susceptibility Testing Market Executive Summary

France Antimicrobial Susceptibility Testing Market is valued at around $94.1 Bn in 2022 and is projected to reach $129.7 Bn by 2030, exhibiting a CAGR of 4.1% during the forecast period 2023-2030.

The Antimicrobial Susceptibility Testing Market refers to the market for instruments, software and methods used for Antimicrobial Susceptibility Testing. For the in vitro diagnostic market, it is important segment and it plays a major role in determining the effectiveness of antimicrobial agents for specific microorganisms.

Increasing prevalence of infectious diseases has contributed the growth of the global market for antimicrobial susceptibility testing. According to WHO, there were around 10.9 million deaths due to infectious diseases in 2022. Most common diseases were lower respiratory diseases, HIV/AIDS, Diarrheal diseases, Tuberculosis, and Malaria. It has increased the growth of market for antimicrobial susceptibility testing.

There are many firms in antimicrobial susceptibility testing market but Bio-Rad Laboratories Inc.; Merck & Co., Inc.; Thermo Fisher Scientific Inc.; Danaher Corporation; BD; bioMérieux SA; Creative Diagnostics; Hi-Media Laboratories Pvt. Ltd.; ELITechGroup; and F. Hoffmann-La Roche Ltd. are some of the major players in market.

Antimicrobial susceptibility testing can be done using a variety of procedures and test, including disk diffusion systems, MIC testing systems, molecular testing systems, automatic AST systems and methods like phenotype testing and genotype testing. All these systems have different type of automation and compatibility with antimicrobial susceptibility testing methods.

Increasing incidence of infectious diseases, increasing funding for research and development, and advancement in technology are projected to fuel the market for coming years. The market may yet have challenges with regard to obtaining regulatory permissions, higher cost of testing systems, limitation for detecting novel pathogens and their resistance mechanism, and lack of awareness and knowledge in healthcare professionals.

Market Dynamics

Drivers of France Antimicrobial Susceptibility Testing Market:

Increasing Prevalence of Infectious Diseases: Global burden of infectious diseases are increasing and most common infectious diseases include pneumonia, tuberculosis, HIV/AIDS and malaria. Novel infectious diseases are also increasing and it increases demand for developing new technologies and therapies for novel infectious diseases. Factors like population growth, urbanization, travel, and changes in healthcare infrastructure are also affecting the prevalence of infectious disease which is driving the demand for antimicrobial susceptibility testing market.

Technological Advancement: There has been continuous new development and advancements in technology for antimicrobial susceptibility testing like automated systems, molecular diagnostic techniques, and rapid AST methods. They provide faster and accurate results. Technological advancement in antimicrobial susceptibility testing has increased adoption in clinical laboratories and healthcare settings.

Increasing Healthcare Expenditure: The market for antimicrobial susceptibility testing is expanding as a result of rising healthcare spending in both developed and developing nations. Growing investment in healthcare infrastructure, laboratory facilities and development in diagnostic technologies has fueled the demand of antimicrobial susceptibility testing.

Emergence of Drug-Resistant Pathogens: increasing number of drug-resistant pathogens has presented a significant challenge to antimicrobial susceptibility market. It has increased a demand to detect resistance pattern and guiding the proper antibiotic drugs to control the spread of resistance. It is fueling the demand for antimicrobial susceptibility testing market.

Growing Interest in Personalized Medicine: demand for personalized medicine has been increasing and antimicrobial susceptibility testing will play a critical role in determining their susceptibility pattern and most effective antimicrobial agents for that pathogen. It is fueling the market for antimicrobial susceptibility testing.

Restraints of France in Antimicrobial Susceptibility Testing Market:

Complex Regulatory Framework: Development and commercialization of new antimicrobial drug has higher time gap because of complex regulatory procedures. It requires lot of time and money for unapproved new medication application. This regulatory barrier hinders the growth of antimicrobial susceptibility testing market.

High Cost: Methods for antimicrobial susceptibility testing are costly and it requires investment in instruments, consumables, skilled professionals and software. Smaller healthcare facilities and institutes can not afford higher cost of antimicrobial susceptibility testing set ups and it may impact the growth of market.

Lack of Awareness: Awareness for antimicrobial resistance has been increasing with time but there is still not enough awareness among healthcare professionals, policymakers and public. It can hinder the growth of antimicrobial susceptibility testing market.

Notable Deals in Antimicrobial Susceptibility Testing Market:

In January 2023, biomerieux has launched an automated instrument for antimicrobial susceptibility testing named MAESTERIA.

In August 2022, BD India has launched the BD MAX MDR-TB panel.

Key players

bioM?rieux SA Thermo Fisher Scientific Inc. BD (Becton, Dickinson and Company) Danaher Corporation Liofilchem s.r.l. Merck KGaA HiMedia Laboratories Biocentric bioM?rieux France G?n?tel

1. Executive Summary
1.1 Service Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Healthcare Services Market in Country
1.6 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Services
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Market Segmentations For France Antimicrobial Susceptibility Testing Market

By Product:

Manual Tests
- MIC Strips
- Susceptibility Testing Disks
- Susceptibility Plates
Automated Instruments
Consumables & Media

By Type:

Antibacterial Susceptibility Testing
Antifungal Susceptibility Testing
Antiparasitic Susceptibility Testing
Other Susceptibility Testing

By Application:

Drug Discovery and Development
Clinical Diagnostics
Epidemiology
Susceptibility Testing
Other Applications

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.